3 ms·
And to add on top of that. If pharmaceuticals could buy out dying patients at a fraction of a cost of even the pre clinical trials to get first human dose there
by isitmadeofglass 4y ago
And to add on top of that. If pharmaceuticals could buy out dying patients at a fraction of a cost of even the pre clinical trials to get first human dose there would no longer be such a thing as “early stage clinical trials”